These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 6273663

  • 1. Measurement of human chorionic gonadotropin.
    Goldstein DP, Berkowitz RS, Kosasa TS.
    Major Probl Obstet Gynecol; 1982; 14():64-97. PubMed ID: 6273663
    [No Abstract] [Full Text] [Related]

  • 2. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
    Jones WB, Lehr M, Lewis JL.
    Surg Forum; 1973; 24():563-5. PubMed ID: 4377042
    [No Abstract] [Full Text] [Related]

  • 3. [Radioimmunoassay of human chorionic gonadotropin--dynamics of human chorionic gonadotropin in chorionic diseases and pregnancy].
    Kato H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1970 Dec; 22(12):1317-26. PubMed ID: 4321386
    [No Abstract] [Full Text] [Related]

  • 4. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ, Ruf H, Blanc B, Gamerre M, Adrai J, Conte M, Dupont S, Bellia-Rousseau J.
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [Abstract] [Full Text] [Related]

  • 5. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M, el-Shobokshy AS, el-Noury AI.
    Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
    [Abstract] [Full Text] [Related]

  • 6. Post-operative follow-up study of trophoblastic tumors using radioimmunoassay for HCG and LH.
    Chen T.
    Acta Obstet Gynaecol Jpn; 1971 Jan; 18(1):13-8. PubMed ID: 4326707
    [No Abstract] [Full Text] [Related]

  • 7. Comparative studies on biological, immunological and biochemical properties of various human chorionic gonadotropins in blood. 1.
    Tokura T.
    Acta Obstet Gynaecol Jpn; 1970 Jul; 17(3):186-97. PubMed ID: 5468865
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of human chorionic gonadotrophin concentrations in the sera of patients with normal and abnormal pregnancy measured by radio-immunoassay and immunoradiometric assay.
    Norman RJ, Buck RH, Joubert SM.
    S Afr Med J; 1989 Apr 01; 75(7):318-9. PubMed ID: 2538933
    [Abstract] [Full Text] [Related]

  • 9. Pregnancy-specific beta-1-glycoprotein in trophoblastic disease.
    Rutanen EM, Seppälä M.
    J Clin Endocrinol Metab; 1980 Jan 01; 50(1):57-61. PubMed ID: 6243133
    [No Abstract] [Full Text] [Related]

  • 10. Laboratory assessment of disappearance patterns of human chorionic gonadotropin from serum of patients with gestational trophoblastic disease.
    Boots LR, Hatch KD, Younger JB.
    Ala J Med Sci; 1983 Oct 01; 20(4):391-4. PubMed ID: 6316799
    [No Abstract] [Full Text] [Related]

  • 11. The management of patients with gestational trophoblastic neoplasia based on the antigenic properties of human chorionic gonadotropin.
    Goldstein DP, Nudemberg F, Lymeburner N, Levesque L, Shore C.
    J Surg Oncol; 1973 Oct 01; 5(1):1-8. PubMed ID: 4736212
    [No Abstract] [Full Text] [Related]

  • 12. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI, Kacinski BM, Stanley ER.
    Gynecol Oncol; 2001 Mar 01; 80(3):383-6. PubMed ID: 11263936
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
    Takayama M, Soma H, Isaka K, Okudera K, Ogawa T, Kikuchi K.
    Gynecol Obstet Invest; 1987 Mar 01; 23(3):151-6. PubMed ID: 3036671
    [Abstract] [Full Text] [Related]

  • 14. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
    Ozturk M, Berkowitz R, Goldstein D, Bellet D, Wands JR.
    Am J Obstet Gynecol; 1988 Jan 01; 158(1):193-8. PubMed ID: 2447774
    [Abstract] [Full Text] [Related]

  • 15. Serum placental lactogen activity in patients with molar pregnancy and trophoblastic tumors--a reliable index of malignancy.
    Goldstein DP.
    Am J Obstet Gynecol; 1971 Jun 15; 110(4):583-7. PubMed ID: 4325820
    [No Abstract] [Full Text] [Related]

  • 16. [HCG and SP1 in serum of patients with hydatidiform mole and chorionepithelioma--relative serum levels of both proteins in correlation to malignancy of the trophoblastic disease].
    Braun P, Leyendecker G.
    Arch Gynecol; 1979 Jul 20; 228(1-4):663-4. PubMed ID: 485549
    [No Abstract] [Full Text] [Related]

  • 17. Use of an immunoradiometric assay and a radioimmunoassay for the detection of free beta-human chorionic gonadotropin.
    Shapiro AI, Wu TF, Ballon SC, Lamb EJ.
    Obstet Gynecol; 1985 Apr 20; 65(4):545-9. PubMed ID: 2580254
    [Abstract] [Full Text] [Related]

  • 18. What are we measuring in gonadotropin assays?
    Jeffcoate SL.
    Acta Endocrinol Suppl (Copenh); 1988 Apr 20; 288():28-30. PubMed ID: 3048031
    [No Abstract] [Full Text] [Related]

  • 19. [HCG in patients with hydatidiform mole or chorionepithelioma].
    Rjosk HK, Gokel JM, Holzmann K.
    Arch Gynecol; 1979 Jul 20; 228(1-4):667-8. PubMed ID: 485551
    [No Abstract] [Full Text] [Related]

  • 20. The beta-subunit of chorionic gonadotrophin as a tumour marker in gestational trophoblastic disease.
    Khoo SK, Daunter B.
    Aust N Z J Obstet Gynaecol; 1980 Feb 20; 20(1):35-42. PubMed ID: 6248013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.